You are here

  • Home
  • Archive
  • Volume 78, Issue Suppl 2
  • OP0029 SWITCHING BETWEEN THE JAK1-SELECTIVE INHIBITOR-UPADACITINIB AND ADALIMUMAB FOLLOWING INITIAL NON-RESPONSE: CLINICAL AND FUNCTIONAL OUTCOMES AMONG RHEUMATOID ARTHRITIS PATIENTS

Article metrics

Article menu

Download PDFPDF

Oral Presentations
WEDNESDAY, 12 JUNE 2019
RA therapy –JAK inhibitors and beyond
OP0029 SWITCHING BETWEEN THE JAK1-SELECTIVE INHIBITOR-UPADACITINIB AND ADALIMUMAB FOLLOWING INITIAL NON-RESPONSE: CLINICAL AND FUNCTIONAL OUTCOMES AMONG RHEUMATOID ARTHRITIS PATIENTS
Free

 

Online download statistics by month:

Online download statistics by month: May 2019 to March 2024

AbstractFullPdf
May 20191401
Jun 2019186059
Jul 201985021
Aug 201993020
Sep 201959014
Oct 201974015
Nov 201976015
Dec 201984014
Jan 202049012
Feb 20202502
Mar 20203507
Apr 20204004
May 20204005
Jun 202060012
Jul 20202703
Aug 20203506
Sep 20205304
Oct 202061011
Nov 20204908
Dec 202032010
Jan 20213403
Feb 20212809
Mar 20215204
Apr 20213801
May 2021702
Jun 2021301
Jul 20210012
Aug 2021103
Sep 20212011
Oct 202144020
Nov 202126012
Dec 20214405
Jan 20223105
Feb 20223406
Mar 20222203
Apr 20222509
May 20223709
Jun 20221806
Jul 20221801
Aug 20221601
Sep 202229011
Oct 20221204
Nov 20221407
Dec 20221403
Jan 20232602
Feb 20231706
Mar 20231603
Apr 20238011
May 20231402
Jun 20231806
Jul 20231204
Aug 20231202
Sep 20231401
Oct 20231402
Nov 20232906
Dec 20232301
Jan 20242000
Feb 20241201
Mar 20241007
Total19710445